Quarterly report · Q1
7745.TEDINET S100RNZL
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥59.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥219m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥7.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥6m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥836m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥159m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥839m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥153m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥68.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥69.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥64.5bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.6bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥36.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥33.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥32.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥31.1bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.47 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.83 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.44 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥201.14 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.2% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 98
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥5.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥5.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥586m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.1bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥63m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥138m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥668m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥85m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥97m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥149m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥148m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥11m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥128m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥650m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥209m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2.2bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥436m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥941m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥55m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥9.2bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥4.2bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥800m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥941m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.6bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥116m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥917m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥132m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥231m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥230m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥15m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥652m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥792m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 6254000000 | JPY |
| Other cl | CurrentQuarterInstant | 6287000000 | JPY |
| Current liabilities | Prior1YearInstant | 31202000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 30146000000 | JPY |
| Long term loans payable | Prior1YearInstant | 3292000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 2986000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | － | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 112000000 | JPY |
| Provision for product warranties ncl | Prior1YearInstant | 54000000 | JPY |
| Provision for product warranties ncl | CurrentQuarterInstant | 57000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1064000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1083000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 92000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | CurrentQuarterInstant | 96000000 | JPY |
| Other ncl | Prior1YearInstant | 1135000000 | JPY |
| Other ncl | CurrentQuarterInstant | 1105000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 5640000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 5442000000 | JPY |
| Liabilities | Prior1YearInstant | 36843000000 | JPY |
| Liabilities | CurrentQuarterInstant | 35589000000 | JPY |
| Capital stock | Prior1YearInstant | 6388000000 | JPY |
| Capital stock | CurrentQuarterInstant | 6388000000 | JPY |
| Capital surplus | Prior1YearInstant | 8319000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 8319000000 | JPY |
| Retained earnings | Prior1YearInstant | 19142000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 19424000000 | JPY |
| Treasury stock | Prior1YearInstant | -172000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -175000000 | JPY |
| Shareholders equity | Prior1YearInstant | 33677000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 33957000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 31000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 37000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -1250000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -787000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 43000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 31000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -1175000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -718000000 | JPY |
| Non controlling interests | Prior1YearInstant | 72000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 80000000 | JPY |
| Net assets | Prior1YearInstant | 32574000000 | JPY |
| Net assets | CurrentQuarterInstant | 33319000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 69418000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 68908000000 | JPY |
| Net sales | Prior1YTDDuration | 11981000000 | JPY |
| Net sales | CurrentYTDDuration | 13387000000 | JPY |
| Cost of sales | Prior1YTDDuration | 7604000000 | JPY |
| Cost of sales | CurrentYTDDuration | 7447000000 | JPY |
| Gross profit | Prior1YTDDuration | 4376000000 | JPY |
| Gross profit | CurrentYTDDuration | 5940000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |